Tamila J Stott Reynolds

Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer.

B. Rogers, Charles J. Smith, Y. Miao, 2018, Nuclear medicine and biology.

Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.

T. Hoffman, Dijie Liu, T. Rold, 2015, Nuclear medicine and biology.

Peptide-Based Radiopharmaceuticals for Molecular Imaging of Prostate Cancer.

Charles J. Smith, Tamila J Stott Reynolds, M. Lewis, 2018, Advances in experimental medicine and biology.